tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR

Arrowhead Pharmaceuticals (ARWR) Stock Investors

1,365 Followers
Based on 730,435 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ARWR
On average, investors allocate 3.71% of their portfolios to ARWR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ARWR

0.3%
Last 7
Days
6.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ARWR, out of 730,435 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ARWR Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
2.86%
$30.35
Increased
0.25%
$28.61
Opened
0.00%
$21.20
Increased
<0.01%
$34.08
Reduced
0.01%
$35.11
Opened
0.39%
$28.24
Increased
3.16%
$34.08
Based on the activity of 13,718 investors who made their portfolios public
The table shows changes in ARWR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ARWR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.12%
+0.29%
+1.57%
321.34B
Healthcare
Trade Desk
4.69%
-0.09%
-1.89%
39.64B
Technology
Block
4.49%
-0.83%
-5.04%
46.31B
Technology
ServiceNow
4.03%
+1.72%
+0.88%
151.89B
Technology
GE Aerospace
5.52%
+1.76%
+11.46%
177.79B
Industrials
Micron
5.72%
+0.65%
+9.26%
124.53B
Technology
Mercadolibre
5.25%
-0.77%
-0.19%
70.72B
Consumer Cyclical
Cisco Systems
4.53%
-0.14%
-1.38%
195.66B
Technology
Boeing
5.82%
-0.29%
+0.18%
103.22B
Industrials
AbbVie
5.70%
<+0.01%
-0.17%
300.20B
Healthcare
Based on the activity of 730,435 active portfolios
Open your Smart Portfolio

ARWR Investor Analysis

ARWR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.4%
of ARWR holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
ARWR investors between 35–55

Between 35–55

3.2%
Last 30 days
Holdings Change
51.0%
of ARWR holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
ARWR investors over 55

Over 55

3.5%
Last 30 days
Holdings Change
42.7%
of ARWR holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of ARWR stock investors
See who invests in ARWR according to age group and performance.

FAQ

How many retail Investors hold ARWR?
<0.1% of TipRanks' retail investors hold ARWR in their portfolios.
    What is ARWR Investor Sentiment?
    ARWR’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ARWR in the last 7 days?
      ▼ 0.3% of TipRanks' retail investors changed their holding of ARWR in the last 7 days.
        What percentage of retail investors changed their holding of ARWR in the last 30 days?
        ▼ 6.0% of TipRanks' retail investors changed their holding of ARWR in the last 30 days.
          What is the average age of retail investors who hold ARWR?
          The average age of ARWR Holders is between 35–55.
            What other stocks have ARWR investors also bought?
            ARWR Investors also bought MRK, TTD, SQ, NOW, GE, MU, MELI, CSCO, BA, ABBV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CORTCorcept Therapeutics
              GERNGeron
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis